Alzheimer’s Prevention Clinical Trials

Help Us Get AHEAD of Alzheimer’s Disease.

Changes in the brains of people with Alzheimer’s Disease can begin up to 20 years before symptoms appear. The AHEAD Study tests whether intervening AHEAD of symptoms may help prevent future memory loss and dementia caused by Alzheimer’s Disease.

The study looks at an investigational treatment aimed at delaying memory decline in people up to 20 years before the symptoms of Alzheimer’s Disease appear. Discovering a treatment that targets brain changes early means doctors may be able to one day prevent memory loss.

To be eligible you must:

  • Be a healthy, non-smoking adult between the ages of 55 and 80.
  • Have not been diagnosed with Alzheimer’s Disease.
  • Have elevated or intermediate levels of amyloid in the brain (a protein shown by brain imaging, as part of the study screening process).

Those that qualify may:

  • Receive access to potential new treatment options before the general public
  • Receive study-related diagnostic tests, lab work and medical exams provided at no cost
  • Receive compensation for time and travel associated with participation

No insurance is required to participate.

For more information, and to see if you qualify, please contact us today!
  • Please do NOT enter 1 before the area code.
  • This field is for validation purposes and should be left unchanged.
Hidradenitis Suppurativa (HS)